Sr. Director, Clinical Scientist

• Serve as the clinical science lead for assigned CAR-T programs, partnering with the Medical Director on the design, execution, and interpretation of clinical studies across all phases of development
• Author and oversee key clinical documents — including protocols, amendments, informed consent forms, investigator brochures, clinical study reports, and regulatory submissions (e.g., INDs, CTAs, DSURs, BLAs/MAAs)
• Review, analyze, and interpret emerging clinical data (safety, efficacy, PK/PD) to identify trends and issues, ensuring timely resolution through cross-functional collaboration
• Conduct literature and competitive landscape reviews to inform study design, data interpretation, and program strategy
• Provide ongoing data review to ensure study conduct aligns with protocol, patient safety standards, and data integrity expectations
• Collaborate with the Medical Monitor to ensure awareness of key safety and efficacy findings, supporting SAE review, narrative development, and safety governance activities
• Lead or support governance activities, including preparation and presentation of materials for Development, Executive, and Scientific Steering Committees, as well as oversight of external boards (e.g., DSMB, adjudication committees)
• Contribute to and present scientific and clinical data internally and externally (e.g., investigator meetings, scientific conferences, regulatory interactions)
• Serve as the clinical science representative on cross-functional development and study teams, providing scientific and strategic input to ensure cohesive execution
• Mentor study team members and contribute to vendor oversight to ensure consistency, quality, and scientific rigor across all clinical deliverables
• Maintain awareness of emerging scientific and regulatory trends in cell and gene therapy and autoimmune diseases to integrate innovations into development strategy.

• Advanced degree (MS, Ph.D., Pharm.D., M.D., or equivalent) in a relevant scientific discipline preferred
• 7+ years of clinical development experience within biotech, pharmaceutical, or academic settings, with demonstrated leadership in advancing programs through early and late-stage development
• Cell and gene therapy experience—particularly in CAR-T or T-cell–based modalities—strongly preferred
• autoimmune disease experience highly desirable
• Deep understanding of T-cell biology, immunology, and translational science principles relevant to cellular therapy
• Proven ability to author and critically review clinical protocols, study reports, and regulatory documents, ensuring scientific integrity and compliance with ICH-GCP and global regulatory standards
• Demonstrated skill in analyzing complex clinical data, conducting literature reviews, and synthesizing insights to inform program strategy
• Exceptional scientific judgment, attention to detail, and analytical rigor
• Strong communication and collaboration skills, with the ability to influence and partner effectively across cross-functional teams, investigators, and external experts
• Highly organized with the ability to manage multiple priorities in a fast-paced, evolving environment.

health and retirement, PTO, and stock option plans